Thank you.
Actually, that's a great segue, because that's what I want you to elaborate on, Mr. Skinner. In your opening remarks you talked about the seven-year delay and the 90-some per cent of products that were available to EU members or U.K. members, and not to Canada. Could you just elaborate on that information for the members of the committee? Just repeat what you said earlier and give us some more examples.